Year: 2023

TAK_Logo

The New England Journal of Medicine Publishes Data from Phase 2 Study of First Oral Orexin Receptor 2 Agonist TAK-994 in Patients with Narcolepsy Type 1

Trial Was Stopped Due to Hepatotoxicity and Consequently TAK-994 Program Terminated for Further Development In Patients with Narcolepsy Type 1,...

EmbassyREITLogo_copy

Embassy REIT Reports Robust Operating and Financial Results for 1Q FY2024: Delivers 1.1 Million Square Feet of Total Leases and Provides Guidance for Full-Year FY2024

WhatsApp_Image_2023-07-25_at_18.12.55

Brenmiller Signs MoU with India’s Largest Solar Panel Manufacturer Waaree Energies to Deploy Thermal Energy Storage Projects in India

Marks Brenmiller’s entrance into the Indian market, the world’s 5th largest economy Solar-powered bGen™ thermal energy storage systems will help...